Aberrant mRNA in Parkinsonism: support for hypothesis from studies with chloramphenicol.
D002701:Chloramphenicol / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D008297:Male; D010300:Parkinson Disease / Q000188:drug therapy* / Q000209:etiology; D012333:RNA, Messenger / Q000378:metabolism*
D012333:RNA, Messenger; D002701:Chloramphenicol